HOME >> MEDICINE >> NEWS
Osteoporosis Drug Evista (Raloxifene) Cuts Newly Diagnosed, Invasive Breast Cancer Risk By More Than 60 Percent

SAN ANTONIO --- New research findings show that the osteoporosis preventive drug raloxifene (Evista®) reduces risk for newly diagnosed, invasive breast cancer -- potentially the most serious type of the disease-- by more than 60 percent.

Noted breast cancer researcher V. Craig Jordan will discuss these findings, which are the latest results from Eli Lilly and Company's ongoing studies of raloxifene, at the 21st San Antonio Breast Cancer Symposium in San Antonio, Tex., on Saturday, Dec. 12.

Jordan, a professor of cancer pharmacology at Northwestern University Medical School, is also director of the Breast Cancer Research Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Raloxifene is the first osteoporosis preventive drug to show reduction in the risk of breast cancer in clinical trials among women at average risk for developing breast cancer.

Over 10,000 postmenopausal women age 31 to 80 taking raloxifene for more than three years had a 63 percent reduction in the incidence of newly diagnosed, invasive breast cancers when compared to their counterparts taking placebo. These women also showed a 55 percent overall reduction in both newly diagnosed invasive and non-invasive breast cancer.

These data were gathered from 10 randomized, double-blind, placebo-controlled osteoporosis studies. The women were taking daily raloxifene therapy for a follow-up of 40 to 55 months. Mammograms were routinely performed on an annual or biannual basis in all placebo-controlled trials of at least 12-months' duration.

The data are an update from those Jordan presented earlier this year at the American Society of Clinical Oncology.

The cancer preventive potential of raloxifene will be further explored in the upcoming Study of Tamoxifen and Raloxifene (STAR) trial, a landmark breast cancer prevention trial comparing the ability of tamoxifen and raloxifene
'"/>

Contact: Elizabeth Crown
e-crown@nwu.edu
312-503-8928
Northwestern University
11-Dec-1998


Page: 1 2

Related medicine news :

1. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
2. ACP-ASIM books program publishes Osteoporosis
3. Osteoporosis is costly for Californians, according to UCSF researchers
4. Osteoporosis drug rapidly reduces risk of bone fractures: one year of treatmentsignificantly decreases occurence of spinal fractures
5. News About Osteoporosis: Fruits And Vegetables Prevent Bone Decay
6. UCSF Study Shows Drug Reduces Risk Of Spine And Hip Fractures By Half In Women With Osteoporosis
7. Signal Pharmaceuticals Announces Positive Results In Preclinical Study Of Novel Drug Leads For Treatment Of Osteoporosis
8. UNC-CH Studies Show Medicine Can Reverse Osteoporosis From Transplants, Cystic Fibrosis
9. Study Shows Calcitonin-Salmon Nasal Spray Helps Prevent New Spinal Fractures In Women With Existing Osteoporosis
10. Studies Indicate An Effective Treatment For Steroid-Induced Osteoporosis
11. New Data Show Evista Reduces Spinal Fractures

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Ocean ... face masks to medical first responders across the United States. Since the start ... personal protective equipment (PPE) medical centers , hospitals , firefighters ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... to dental groups in the United States, today announced the grand opening of ... CA. , Patients will enjoy convenient hours, a comfortable office, and full-service ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang ... persons with autism and other developmental disabilities, as well as supporting staff in ... adolescents with autism, school consultation, and staff development. She joined the company in ...
(Date:8/28/2020)... ... 2020 , ... WHAT , Hespiro™ is a new type ... including COVID-19, while reducing the need for scarce mechanical ventilators. It not only ... scrubs it free of carbon dioxide in a completely closed “rebreather” system, important ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... advising Adventist Health on its investment in Synchronous Health, a tech-enabled behavioral health ... combines the strength of human empathy with artificial intelligence (AI) to increase access ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... BETHESDA, Md. (PRWEB) , ... September 02, 2020 , ... ... Dr. Jonathan Lee . Dr. Lee will work at Bethesda Dermatopathology ... graduated with his B.A. from the University of California, Berkley. He went on to ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... Breast and ... of Disease Control (CDC), About 3% of breast cancers (about 7,500 women per year) ... in the BRCA1 and BRCA2 genes. Both genes are detectable in the Women’s ...
(Date:8/31/2020)... ... 2020 , ... Cloudticity announced today that Network Products Guide, ... in the 15th Annual 2020 Network PG’s IT World Awards®. , The IT ... Products Guide honoring achievements of world’s best in organizational performance, product and service ...
Breaking Medicine Technology:
Cached News: